If you've ever taken an at-home diagnostic test for COVID-19, you can partially credit the technology to the Johns Hopkins University Center for Innovative Diagnostics for Infectious Diseases (CIDID).
Adial Pharmaceuticals, a clinical-stage biopharmaceutical company, announced that the US Food and Drug Administration (FDA) have issued an emergency use authorization (EUA) for the Assure/FaStep COVID ...
Hosted on MSN
WHO prequalifies first rapid antigen tests for COVID-19, strengthening global diagnostic preparedness
More than two years after the World Health Organization (WHO) declared an end to the emergency phase of the Covid-19 pandemic, the virus continues to circulate globally. While current data suggest ...
Rapid antimicrobial susceptibility testing for gram-negative blood infections shows no improvement in clinical outcomes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results